Investors
1 investorAll
Early stage
Mid stage
Late stage
Investor geography1 country
Frequently asked questions
Who invested in Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+)?
Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) last raise funding?
The most recent investment in Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) recorded on gritt.io was in October 2025.
When was Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) founded?
Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) was founded in 2025.
What industry is Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) in?
Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) based?
Antimicrobial Resistance & ID, Genomics & Transcriptomics, Epidemiology & Data Science (AGE+) is headquartered in Groningen, Netherlands.
